Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)
This study has been completed.
Study NCT00890565   Information provided by Prostrakan Pharmaceuticals

First Received on April 29, 2009.   Last Updated on September 24, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
granisetron
Additional drug interventions recognized in this trial
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
More general drug interventions related to this trial
Anti-Infective Agents
Antiemetics
Autonomic Agents
Central Nervous System Agents
Contraceptive Agents
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Combined
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Sponsors listed in this trial
Prostrakan Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services